[TOP STORY] Compounded weight-loss drugs raise serious patient safety concerns

Loading player...
‘I think the main concern with compounded GLP-1s, is that they are not actually assessed or tested by the applicable regulators,’ says Charles Green, healthcare and pharmaceutical expert at Cliffe Dekker Hofmeyr.
15 May 8AM English South Africa Business News · Politics

Other recent episodes

[TOP STORY] Popia enforcement gains teeth, but a critical loophole remains

‘That grace period for us is a problem, because if you look at our counterparts elsewhere in the world, once they find that the legislation has been infringed or violated, they impose a fine that has to be paid immediately,’ says Advocate Pansy Tlakula, chair of the Information Regulator.
2 Sep 8AM 8 min